Current concepts in the pathogenesis and clinical management of lymphangioleiomyomatosis.
Journal:
Current opinion in pulmonary medicine
Published Date:
Jun 13, 2025
Abstract
PURPOSE OF REVIEW: Lymphangioleiomyomatosis (LAM) is a systemic, low-grade, metastasizing neoplasm that predominantly affects women. This review demonstrates recent progression in this rare disease, from improved understanding of pathogenesis, to novel treatments. We provide an overview of recent advances that are shaping the future of LAM diagnostic and treatment approaches.
Authors
Keywords
No keywords available for this article.